Position in NERV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,075,701
+$2,101,314 QoQ
Shares Held
2,175,802
+31.4% QoQ
Ownership
4.56%
of shares outstanding
% of Portfolio
15.56%
of 13F equity value
Holder Rank
#8
of 58 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ally Bridge Group (NY) LLC holds $75,058,438 across 22 Biotechnology names. NERV ranks #1 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NERV |
Minerva Neurosciences, Inc.
This page
|
2,175,802 | $12,075,701 | |
| 2 | PMN |
ProMIS Neurosciences Inc.
|
620,319 | $8,163,398 | |
| 3 | TRAX |
First Tracks Biotherapeutics, Inc.
|
284,287 | $5,719,854 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
16,493 | $4,036,991 | |
| 5 | ASMB |
Assembly Biosciences, Inc.
|
140,000 | $3,847,200 | |
| 6 | WHWK |
Whitehawk Therapeutics, Inc.
|
817,939 | $3,746,160 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
83,300 | $3,384,479 | |
| 8 | CLYM |
Climb Bio, Inc.
|
249,172 | $3,249,202 |
All Filings in NERV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,075,701 | 2,175,802 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,974,387 | 1,655,500 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $6,655,110 | 1,655,500 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||